PROTHROMPLEX Trademark

Trademark Overview

On Wednesday, January 26, 2022, a trademark application was filed for PROTHROMPLEX with the United States Patent and Trademark Office. The USPTO has given the PROTHROMPLEX trademark a serial number of 97239683. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, August 6, 2024. This trademark is owned by Baxalta Incorporated. The PROTHROMPLEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, blood plasma protein that is converted into thrombin during blood clotting
prothromplex

General Information

Serial Number97239683
Word MarkPROTHROMPLEX
Filing DateWednesday, January 26, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, August 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 31, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, blood plasma protein that is converted into thrombin during blood clotting

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBaxalta Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBannockburn, IL 60015
Party NameBaxalta Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBannockburn, IL 60015

Trademark Events

Event DateEvent Description
Saturday, January 29, 2022NEW APPLICATION ENTERED
Monday, January 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, June 26, 2022ASSIGNED TO EXAMINER
Monday, June 27, 2022NON-FINAL ACTION WRITTEN
Monday, June 27, 2022NON-FINAL ACTION E-MAILED
Monday, June 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 31, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 9, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 9, 2023SOU EXTENSION 1 FILED
Friday, June 9, 2023SOU EXTENSION 1 GRANTED
Tuesday, June 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 6, 2024SOU EXTENSION 2 FILED
Tuesday, February 6, 2024SOU EXTENSION 2 GRANTED
Tuesday, August 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 6, 2024SOU EXTENSION 3 GRANTED
Tuesday, August 6, 2024SOU EXTENSION 3 FILED
Tuesday, August 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

prothromplex blood thrombin during clotting converted plasma preparations namely pharmaceutical protein